Entero Healthcare Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Financial results ....
ENTERO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Entero Healthcare Solutions has informed the stock exchanges that its Board of Directors will meet on Wednesday, November 12, 2025. The main agenda is to consider, approve, and take on record the Unaudited Standalone and Consolidated Financial Results, along with the Limited Review report, for the quarter and half year ended September 30, 2025. The company has also confirmed that the trading window for dealing in its securities is closed for all designated persons and their immediate relatives from October 1, 2025, and will remain closed until 48 hours after the financial results are uploaded to the stock exchanges. The intimation has been filed under Regulation 29 of the SEBI Listing Regulations.
This is a routine pre-results intimation and does not contain any financial figures. Investors should watch for the Q2/H1 FY26 results on or after November 12, 2025, as they will provide an update on the company's financial performance. The closed trading window means insiders cannot trade until results are publicly disclosed.